1. Home
  2. ICON vs WINT Comparison

ICON vs WINT Comparison

Compare ICON & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICON
  • WINT
  • Stock Information
  • Founded
  • ICON 2023
  • WINT 1992
  • Country
  • ICON Greece
  • WINT United States
  • Employees
  • ICON N/A
  • WINT N/A
  • Industry
  • ICON
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ICON
  • WINT Health Care
  • Exchange
  • ICON Nasdaq
  • WINT Nasdaq
  • Market Cap
  • ICON 3.6M
  • WINT 3.6M
  • IPO Year
  • ICON 2024
  • WINT 1995
  • Fundamental
  • Price
  • ICON $1.79
  • WINT $0.83
  • Analyst Decision
  • ICON Strong Buy
  • WINT Hold
  • Analyst Count
  • ICON 1
  • WINT 1
  • Target Price
  • ICON $4.50
  • WINT $350.00
  • AVG Volume (30 Days)
  • ICON 116.0K
  • WINT 224.2K
  • Earning Date
  • ICON 05-23-2025
  • WINT 05-16-2025
  • Dividend Yield
  • ICON 195.06%
  • WINT N/A
  • EPS Growth
  • ICON N/A
  • WINT N/A
  • EPS
  • ICON N/A
  • WINT N/A
  • Revenue
  • ICON $5,309,000.00
  • WINT N/A
  • Revenue This Year
  • ICON $76.76
  • WINT N/A
  • Revenue Next Year
  • ICON $30.43
  • WINT N/A
  • P/E Ratio
  • ICON N/A
  • WINT N/A
  • Revenue Growth
  • ICON 18.61
  • WINT N/A
  • 52 Week Low
  • ICON $1.60
  • WINT $1.01
  • 52 Week High
  • ICON $154.00
  • WINT $737.50
  • Technical
  • Relative Strength Index (RSI)
  • ICON N/A
  • WINT 29.36
  • Support Level
  • ICON N/A
  • WINT $0.81
  • Resistance Level
  • ICON N/A
  • WINT $0.95
  • Average True Range (ATR)
  • ICON 0.00
  • WINT 0.09
  • MACD
  • ICON 0.00
  • WINT 0.04
  • Stochastic Oscillator
  • ICON 0.00
  • WINT 6.14

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: